These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 25497376)

  • 21. Bisphosphonate-related osteonecrosis of the jaws.
    Kushner GM; Alpert B
    Curr Opin Otolaryngol Head Neck Surg; 2011 Aug; 19(4):302-6. PubMed ID: 21677585
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Jaw osteonecrosis induced by oral biphosphonates: 12 cases].
    Barrier A; Lescaille G; Rigolet A; Descroix V; Goudot P; Ruhin B
    Rev Stomatol Chir Maxillofac; 2010 Sep; 111(4):196-202. PubMed ID: 20810140
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The role of surgical resection in the management of bisphosphonate-related osteonecrosis of the jaws.
    Carlson ER; Basile JD
    J Oral Maxillofac Surg; 2009 May; 67(5 Suppl):85-95. PubMed ID: 19371819
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Osteonecrosis of the jaws in patients treated with intravenous bisphosphonates (BRONJ): A concise update.
    Bagan J; Scully C; Sabater V; Jimenez Y
    Oral Oncol; 2009 Jul; 45(7):551-4. PubMed ID: 19251474
    [TBL] [Abstract][Full Text] [Related]  

  • 25. National Survey on Bisphosphonate-Related Osteonecrosis of the Jaws in Japan.
    Shibahara T; Morikawa T; Yago K; Kishimoto H; Imai Y; Kurita K
    J Oral Maxillofac Surg; 2018 Oct; 76(10):2105-2112. PubMed ID: 29746838
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Bisphosphonate-related osteonecrosis of the jaw].
    Franken AA; van Blijderveen NJ; Witjes MJ; Netelenbos CJ
    Ned Tijdschr Geneeskd; 2011; 155():A3077. PubMed ID: 21486510
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long-term oral bisphosphonates delay healing after tooth extraction: a single institutional prospective study.
    Shudo A; Kishimoto H; Takaoka K; Noguchi K
    Osteoporos Int; 2018 Oct; 29(10):2315-2321. PubMed ID: 29967931
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bisphosphonate-associated osteonecrosis of the jaw in Ontario: a survey of oral and maxillofacial surgeons.
    Khan AA; Rios LP; Sándor GK; Khan N; Peters E; Rahman MO; Clokie CM; Dore E; Dubois S
    J Rheumatol; 2011 Jul; 38(7):1396-402. PubMed ID: 21498483
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The characteristics of bisphosphonate patients developing bisphosphonate-related osteonecrosis of the jaw attending an OMFS department.
    Serrant PS; Clark S
    Dent Update; 2013 Nov; 40(9):740-2. PubMed ID: 24386766
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intravenous bisphosphonate-related osteonecrosis of the jaw: bone scintigraphy as an early indicator.
    O'Ryan FS; Khoury S; Liao W; Han MM; Hui RL; Baer D; Martin D; Liberty D; Lo JC
    J Oral Maxillofac Surg; 2009 Jul; 67(7):1363-72. PubMed ID: 19531404
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Incidence of bisphosphonate-related osteonecrosis of the jaw in consideration of primary diseases and concomitant therapies.
    Assaf AT; Smeets R; Riecke B; Weise E; Gröbe A; Blessmann M; Steiner T; Wikner J; Friedrich RE; Heiland M; Hoelzle F; Gerhards F
    Anticancer Res; 2013 Sep; 33(9):3917-24. PubMed ID: 24023329
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A survey of consultant members of the British Association of Oral and Maxillofacial Surgeons regarding bisphosphonate-induced osteonecrosis of the jaws.
    Rogers SN; Hung J; Barber AJ; Lowe D
    Br J Oral Maxillofac Surg; 2009 Dec; 47(8):598-601. PubMed ID: 19748711
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Incidence of bisphosphonate-related osteonecrosis of the jaw in high-risk patients undergoing surgical tooth extraction.
    Bodem JP; Kargus S; Eckstein S; Saure D; Engel M; Hoffmann J; Freudlsperger C
    J Craniomaxillofac Surg; 2015 May; 43(4):510-4. PubMed ID: 25841311
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Epidemiology, pharmacology and clinical characterization of bisphosphonate-related osteonecrosis of the jaw. A retrospective study of 70 cases.
    Pelaz A; Junquera L; Gallego L; García-Consuegra L; García-Martínez L; Cutilli T; Olay S
    Acta Otorrinolaringol Esp; 2015; 66(3):139-47. PubMed ID: 25308796
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Adverse events and intravenous versus oral bisphosphonate use in patients with osteoporosis and cancer in the U.S.
    Skrepnek GH; Seal B; Tangirala M; Jeffcoat MK; Watts NB; Hay JW
    Gen Dent; 2010; 58(6):484-92; quiz 493-4. PubMed ID: 21062718
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prevalence and risk factors of bisphosphonate-associated osteonecrosis of the jaw in prostate cancer patients with advanced disease treated with zoledronate.
    Walter C; Al-Nawas B; Grötz KA; Thomas C; Thüroff JW; Zinser V; Gamm H; Beck J; Wagner W
    Eur Urol; 2008 Nov; 54(5):1066-72. PubMed ID: 18602738
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Osteoporosis and bisphosphonates-related osteonecrosis of the jaw: not just a sporadic coincidence--a multi-centre study.
    Otto S; Abu-Id MH; Fedele S; Warnke PH; Becker ST; Kolk A; Mücke T; Mast G; Köhnke R; Volkmer E; Haasters F; Lieger O; Iizuka T; Porter S; Campisi G; Colella G; Ploder O; Neff A; Wiltfang J; Ehrenfeld M; Kreusch T; Wolff KD; Stürzenbaum SR; Schieker M; Pautke C
    J Craniomaxillofac Surg; 2011 Jun; 39(4):272-7. PubMed ID: 20580566
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The oral health status of patients on oral bisphosphonates for osteoporosis.
    Kunchur R; Goss AN
    Aust Dent J; 2008 Dec; 53(4):354-7; quiz 366. PubMed ID: 19133952
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Outcomes of placing dental implants in patients taking oral bisphosphonates: a review of 115 cases.
    Grant BT; Amenedo C; Freeman K; Kraut RA
    J Oral Maxillofac Surg; 2008 Feb; 66(2):223-30. PubMed ID: 18201600
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Oral health considerations in older women receiving oral bisphosphonate therapy.
    Lo JC; O'Ryan F; Yang J; Hararah MK; Gonzalez JR; Gordon N; Silver P; Ansfield A; Wang B; Go AS
    J Am Geriatr Soc; 2011 May; 59(5):916-22. PubMed ID: 21539523
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.